Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$1.36
-0.99%
Mkt Cap $878.88M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
Implied Upside
+334.7%
Consensus $5.89 vs current $1.36
NASDAQ·Healthcare·Biotechnology
$1.36
-0.99%
Mkt Cap $878.88M
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
+334.7%
Consensus $5.89 vs current $1.36